Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO15310 | Oxytropis oxyphylla | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO14995 | Chloranthus spicatus | Species | Chloranthaceae | Eukaryota | UNPD* | |||
NPO10935 | Chamaepeuce afra | NA | NA | NA | UNPD* | |||
NPO14635 | Thalictrum squarrosum | Species | Ranunculaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2 | Others | Unspecified | Potency | 67823.1 | nM | PubChem BioAssay data set | ||
NPT74 | Individual Protein | Proto-oncogene c-JUN | Homo sapiens | Potency | 54329.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 27000.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 17180.6 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC148385 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9633 | High Similarity | NPC252603 |
0.9273 | High Similarity | NPC278549 |
0.885 | High Similarity | NPC158847 |
0.8739 | High Similarity | NPC256849 |
0.8661 | High Similarity | NPC199790 |
0.8611 | High Similarity | NPC476099 |
0.8393 | Intermediate Similarity | NPC47936 |
0.8246 | Intermediate Similarity | NPC303899 |
0.8053 | Intermediate Similarity | NPC75131 |
0.8017 | Intermediate Similarity | NPC109322 |
0.7951 | Intermediate Similarity | NPC180493 |
0.7788 | Intermediate Similarity | NPC476562 |
0.7611 | Intermediate Similarity | NPC476561 |
0.7333 | Intermediate Similarity | NPC41958 |
0.7328 | Intermediate Similarity | NPC18335 |
0.7167 | Intermediate Similarity | NPC312187 |
0.7167 | Intermediate Similarity | NPC4837 |
0.7132 | Intermediate Similarity | NPC226184 |
0.7132 | Intermediate Similarity | NPC76544 |
0.7132 | Intermediate Similarity | NPC167285 |
0.7063 | Intermediate Similarity | NPC321052 |
0.6991 | Remote Similarity | NPC51000 |
0.6983 | Remote Similarity | NPC293163 |
0.697 | Remote Similarity | NPC246193 |
0.6949 | Remote Similarity | NPC59314 |
0.6923 | Remote Similarity | NPC174114 |
0.6923 | Remote Similarity | NPC87981 |
0.6693 | Remote Similarity | NPC68938 |
0.6693 | Remote Similarity | NPC189314 |
0.6612 | Remote Similarity | NPC476564 |
0.6557 | Remote Similarity | NPC119133 |
0.6519 | Remote Similarity | NPC14330 |
0.6496 | Remote Similarity | NPC9639 |
0.6496 | Remote Similarity | NPC57279 |
0.6471 | Remote Similarity | NPC287876 |
0.6328 | Remote Similarity | NPC313547 |
0.629 | Remote Similarity | NPC155498 |
0.626 | Remote Similarity | NPC10466 |
0.625 | Remote Similarity | NPC144223 |
0.6202 | Remote Similarity | NPC327613 |
0.6133 | Remote Similarity | NPC326694 |
0.6129 | Remote Similarity | NPC111132 |
0.6116 | Remote Similarity | NPC320256 |
0.6115 | Remote Similarity | NPC104011 |
0.5985 | Remote Similarity | NPC15566 |
0.5985 | Remote Similarity | NPC248007 |
0.5852 | Remote Similarity | NPC327579 |
0.584 | Remote Similarity | NPC326248 |
0.584 | Remote Similarity | NPC187191 |
0.5839 | Remote Similarity | NPC5707 |
0.5775 | Remote Similarity | NPC243319 |
0.5766 | Remote Similarity | NPC139776 |
0.5734 | Remote Similarity | NPC25465 |
0.5685 | Remote Similarity | NPC320818 |
0.5669 | Remote Similarity | NPC273327 |
0.5658 | Remote Similarity | NPC197068 |
0.5646 | Remote Similarity | NPC237812 |
0.5646 | Remote Similarity | NPC18223 |
0.5638 | Remote Similarity | NPC317821 |
0.5638 | Remote Similarity | NPC286696 |
0.5638 | Remote Similarity | NPC185903 |
0.5625 | Remote Similarity | NPC235501 |
0.5608 | Remote Similarity | NPC33996 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC148385 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9633 | High Similarity | NPD9292 | Approved |
0.9633 | High Similarity | NPD9289 | Approved |
0.9633 | High Similarity | NPD9288 | Approved |
0.9633 | High Similarity | NPD76 | Approved |
0.9211 | High Similarity | NPD579 | Clinical (unspecified phase) |
0.9074 | High Similarity | NPD8955 | Approved |
0.9074 | High Similarity | NPD8954 | Approved |
0.8739 | High Similarity | NPD9359 | Approved |
0.8739 | High Similarity | NPD9358 | Approved |
0.8421 | Intermediate Similarity | NPD9086 | Approved |
0.8291 | Intermediate Similarity | NPD580 | Discontinued |
0.8151 | Intermediate Similarity | NPD2221 | Clinical (unspecified phase) |
0.8077 | Intermediate Similarity | NPD1117 | Clinical (unspecified phase) |
0.7951 | Intermediate Similarity | NPD9544 | Approved |
0.7951 | Intermediate Similarity | NPD78 | Approved |
0.7899 | Intermediate Similarity | NPD578 | Discontinued |
0.7886 | Intermediate Similarity | NPD281 | Approved |
0.7823 | Intermediate Similarity | NPD1775 | Approved |
0.7823 | Intermediate Similarity | NPD1085 | Approved |
0.776 | Intermediate Similarity | NPD1128 | Approved |
0.776 | Intermediate Similarity | NPD1127 | Approved |
0.7642 | Intermediate Similarity | NPD4262 | Discontinued |
0.7578 | Intermediate Similarity | NPD282 | Approved |
0.7519 | Intermediate Similarity | NPD1118 | Discontinued |
0.7407 | Intermediate Similarity | NPD2179 | Discontinued |
0.7405 | Intermediate Similarity | NPD1119 | Phase 2 |
0.7348 | Intermediate Similarity | NPD535 | Approved |
0.7339 | Intermediate Similarity | NPD9290 | Approved |
0.7328 | Intermediate Similarity | NPD8836 | Approved |
0.7319 | Intermediate Similarity | NPD7531 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD4182 | Phase 3 |
0.7143 | Intermediate Similarity | NPD4183 | Phase 3 |
0.708 | Intermediate Similarity | NPD2253 | Discontinued |
0.704 | Intermediate Similarity | NPD9360 | Approved |
0.6991 | Remote Similarity | NPD8838 | Approved |
0.6949 | Remote Similarity | NPD8837 | Clinical (unspecified phase) |
0.6693 | Remote Similarity | NPD8831 | Approved |
0.6693 | Remote Similarity | NPD8833 | Approved |
0.6667 | Remote Similarity | NPD5321 | Phase 3 |
0.6557 | Remote Similarity | NPD9291 | Approved |
0.6471 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.6449 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.6385 | Remote Similarity | NPD237 | Clinical (unspecified phase) |
0.6287 | Remote Similarity | NPD1250 | Clinical (unspecified phase) |
0.626 | Remote Similarity | NPD341 | Approved |
0.626 | Remote Similarity | NPD340 | Approved |
0.625 | Remote Similarity | NPD3081 | Clinical (unspecified phase) |
0.6235 | Remote Similarity | NPD3041 | Approved |
0.6204 | Remote Similarity | NPD870 | Clinical (unspecified phase) |
0.617 | Remote Similarity | NPD9484 | Clinical (unspecified phase) |
0.6129 | Remote Similarity | NPD8862 | Approved |
0.6129 | Remote Similarity | NPD8859 | Approved |
0.6129 | Remote Similarity | NPD8861 | Approved |
0.6124 | Remote Similarity | NPD9373 | Approved |
0.6058 | Remote Similarity | NPD9408 | Phase 3 |
0.6047 | Remote Similarity | NPD9375 | Discontinued |
0.6043 | Remote Similarity | NPD9633 | Phase 3 |
0.6031 | Remote Similarity | NPD9374 | Approved |
0.6026 | Remote Similarity | NPD3708 | Phase 2 |
0.6014 | Remote Similarity | NPD9627 | Approved |
0.5985 | Remote Similarity | NPD9084 | Phase 2 |
0.5946 | Remote Similarity | NPD3706 | Clinical (unspecified phase) |
0.5946 | Remote Similarity | NPD9704 | Approved |
0.5903 | Remote Similarity | NPD1120 | Approved |
0.5903 | Remote Similarity | NPD1121 | Approved |
0.5899 | Remote Similarity | NPD300 | Approved |
0.5896 | Remote Similarity | NPD9606 | Approved |
0.5887 | Remote Similarity | NPD248 | Discontinued |
0.5859 | Remote Similarity | NPD1816 | Clinical (unspecified phase) |
0.5852 | Remote Similarity | NPD9607 | Approved |
0.5852 | Remote Similarity | NPD307 | Approved |
0.5839 | Remote Similarity | NPD4240 | Approved |
0.5839 | Remote Similarity | NPD8830 | Phase 3 |
0.5822 | Remote Similarity | NPD1808 | Phase 1 |
0.5821 | Remote Similarity | NPD1368 | Approved |
0.5809 | Remote Similarity | NPD9409 | Discontinued |
0.5796 | Remote Similarity | NPD2604 | Approved |
0.5789 | Remote Similarity | NPD757 | Phase 3 |
0.5775 | Remote Similarity | NPD9081 | Clinical (unspecified phase) |
0.5764 | Remote Similarity | NPD209 | Clinical (unspecified phase) |
0.5764 | Remote Similarity | NPD1058 | Discontinued |
0.5762 | Remote Similarity | NPD1730 | Discontinued |
0.5753 | Remote Similarity | NPD9628 | Approved |
0.5743 | Remote Similarity | NPD3696 | Approved |
0.5743 | Remote Similarity | NPD3695 | Approved |
0.5742 | Remote Similarity | NPD9605 | Phase 3 |
0.5732 | Remote Similarity | NPD1017 | Clinical (unspecified phase) |
0.5714 | Remote Similarity | NPD4812 | Phase 1 |
0.5705 | Remote Similarity | NPD1431 | Approved |
0.5705 | Remote Similarity | NPD1430 | Approved |
0.5703 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.5667 | Remote Similarity | NPD2618 | Phase 1 |
0.5646 | Remote Similarity | NPD9133 | Approved |
0.563 | Remote Similarity | NPD9132 | Discontinued |
0.5605 | Remote Similarity | NPD1731 | Clinical (unspecified phase) |
PubChem CID   | 70315 |
ChEMBL   | CHEMBL2396855 |
ZINC   |
Molecular Weight:   | 165.07 |
ALogP:   | -0.9111 |
MLogP:   | 1.46 |
XLogP:   | -0.338 |
# Rotatable Bonds:   | 1 |
Polar Surface Area:   | 84.87 |
# H-Bond Aceptor:   | 6 |
# H-Bond Donor:   | 3 |
# Rings:   | 2 |
# Heavy Atoms:   | 12 |